STORY FROM: Drugs & Medical Devices
Plaintiffs Seek MDL Docket for Linear Gadolinium-Based Contrast Agent Cases
August 1, 2018
WASHINGTON, D.C. –– Plaintiffs asserting claims relating to the retention of toxic gadolinium in their organs, bones, and tissues have filed a petition seeking the creation of a multidistrict litigation docket, arguing that the number of Linear Gadolinium-Based Contrast Agent cases “will likely be in the hundreds or more due to the widespread use of Linear GBCAs in MRI and MRA procedures.”
In the July 31 petition filed in the U.S. Judicial Panel on Multidistrict Litigation, the plaintiffs maintained that transfer and centralization is proper, given that each of the actions arise out of the same or similar nucleus of ...
Associated Law Firms
Cutter Law P.C.